Unknown

Dataset Information

0

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies.


ABSTRACT: We aimed to identify the key players in the prothrombotic profile of patients with systemic lupus erythematosus (SLE) not mediated by antiphospholipid antibodies, as well as the potential utility of global coagulation tests to characterize hemostasis in these patients. Patients with SLE without antiphospholipid antibodies and without signs of thrombosis were included. The kinetics of clot formation were determined by ROTEM®. Platelet activation markers were determined by flow cytometry. Thrombin generation associated with Neutrophil Extracellular Traps (NETs) and microparticles (MPs) was measured by calibrated automated thrombogram (CAT). The plasma levels of PAI-1 were also determined. ROTEM® showed a procoagulant profile in SLE patients. SLE patients had activated platelets and more leukocyte/platelet aggregates at basal conditions. The plasma PAI-1 and platelet aggregates correlated with several ROTEM® parameters. The thrombin generation associated withthe tissue factor (TF) content of MPs and with NETs was increased. Our results suggest the utility of global tests for studying hemostasis in SLE patients because they detect their procoagulant profile, despite having had neither antiphospholipid antibodies nor any previous thrombotic event. A global appraisal of hemostasis should, if possible, be incorporated into clinical practice to detect the risk of a thrombotic event in patients with SLE and to consequently act to prevent its occurrence.

SUBMITTER: Monzon Manzano E 

PROVIDER: S-EPMC7602183 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Insights into the Procoagulant Profile of Patients with Systemic Lupus Erythematosus without Antiphospholipid Antibodies.

Monzón Manzano Elena E   Fernández-Bello Ihosvany I   Justo Sanz Raúl R   Robles Marhuenda Ángel Á   López-Longo Francisco Javier FJ   Acuña Paula P   Álvarez Román María Teresa MT   Jiménez Yuste Víctor V   Butta Nora V NV  

Journal of clinical medicine 20201014 10


We aimed to identify the key players in the prothrombotic profile of patients with systemic lupus erythematosus (SLE) not mediated by antiphospholipid antibodies, as well as the potential utility of global coagulation tests to characterize hemostasis in these patients. Patients with SLE without antiphospholipid antibodies and without signs of thrombosis were included. The kinetics of clot formation were determined by ROTEM<sup>®</sup>. Platelet activation markers were determined by flow cytometr  ...[more]

Similar Datasets

| S-EPMC6514053 | biostudies-literature
| S-EPMC6037302 | biostudies-literature
| S-EPMC8728347 | biostudies-literature
| S-EPMC9967991 | biostudies-literature
| S-EPMC4977549 | biostudies-literature
| S-EPMC3312889 | biostudies-literature
| S-EPMC10252548 | biostudies-literature
| S-EPMC4208791 | biostudies-other
| S-EPMC5554640 | biostudies-other
| S-EPMC7306071 | biostudies-literature